Potentiating CD8+ T cell antitumor activity by targeting the PCSK9/LDLR axis
J. Yuan, T. Cai, X. Zheng…·W. Yang
This study identifies PCSK9 as a target to enhance CD8+ T cell antitumor activity by modulating LDLR and TCR signaling in the tumor microenvironment.